Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer. Wang J, Yang B, Bian L, Zhang H, et al. Ann Surg Oncol 2025 Apr 22. doi: 10.1245/s10434-025-17297.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang J, Yang B, Bian L, Zhang H, et al. Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer. Ann Surg Oncol 2025 Apr 22. doi: 10.1245/s10434-025-17297.
PMID: 40263225